Test Overview
Clinical Utility
CA 19-9 is not specific for pancreatic cancer.
Method
Electrochemiluminescent immunoassay (ECLIA)
Result Included
CA 19-9
Aliases/Synonyms
Cancer Antigen 19-9; CA 199; CA199
Specimen
Specimen Type
SerumVolume
Sample Volume
1 mL
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 7 days | 30 days | 3 months |
Performance & Interpretation
Turnaround Time
3 days
Results
Name
Units
Reference Range
Conversion
-
CA 19-9kU/LLess than 35
Comment
Results must be interpreted in light of other clinical findings
Referral Location
Canada
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| CA199 | CA19-9 | 20851 | kU/L |
Test Version
Last Updated
2019-09-30